{"public_id":"cl_3b73a01fef0af35b1f5b1b01d367ac4d","status":"active","superseded_by_public_id":null,"corpus_id":6888582,"text":"Half-dose verteporfin photodynamic therapy produced complete resolution of subretinal fluid in 96.2% of treated eyes by 3, 6, and 12 months.","confidence":0.98,"paper":{"corpus_id":6888582,"title":"Half-dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy","url":"https://sah.borca.ai/papers/6888582"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.98,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_1327be64d627714ce4748470418a9581","name":"chronic central serous chorioretinopathy","description":"A chronic retinal disorder characterized by persistent serous detachment and subretinal fluid.","types":["condition"],"url":"https://sah.borca.ai/concepts/co_1327be64d627714ce4748470418a9581"},{"public_id":"co_5eb3394dcb06e17a2851d9cfff740232","name":"subretinal fluid","description":"Fluid accumulation beneath the neurosensory retina used as a key treatment outcome.","types":["outcome"],"url":"https://sah.borca.ai/concepts/co_5eb3394dcb06e17a2851d9cfff740232"},{"public_id":"co_9c4cde4692dc3983ddd1fb9cd2b7add5","name":"half-dose verteporfin photodynamic therapy","description":"A photodynamic therapy regimen using a reduced 3 mg/m2 dose of verteporfin.","types":["treatment","method"],"url":"https://sah.borca.ai/concepts/co_9c4cde4692dc3983ddd1fb9cd2b7add5"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_3b73a01fef0af35b1f5b1b01d367ac4d"}